NCT06021483View on ClinicalTrials.gov

Observational Study to Evaluate the Safety and Efficacy of Zepzelca™ Injection

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

August 16, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
SCLC
Trial Locations (1)

Unknown

RECRUITING

Seoul National University Boramae Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY